Seer Q4 Earnings Call Highlights

Farokhzad pointed to several large-scale deployments as evidence of platform adoption, including a 20,000-sample population study with Korea University and a 10,000-sample project in collaboration with Discovery Life Sciences. He said studies of that magnitude were not previously feasible with traditional mass spectrometry proteomics approaches, which he characterized as lacking the depth and scalability needed for standardized processing of tens of thousands of samples.Chief Executive Officer Omid Farokhza ...